Immucell (ICCC) Tax Provisions (2010 - 2026)
Immucell's (ICCC) quarterly Tax Provisions came in at $3306.0 in Q4 2025, down 45.23% YoY from $6036.0 in Q4 2024, and down 25.81% on a QoQ basis from $4456.0 in Q3 2025.
Immucell (ICCC) Tax Provisions (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Tax Provisions data on file, last reported at $3306.0 in Q4 2025.
- Quarterly Tax Provisions fell 45.23% year-over-year to $3306.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11570.0 (up 15.06% YoY) and the FY2025 annual result came in at $11570.0, up 15.06% from the prior year.
- Tax Provisions slipped to $3306.0 in Q4 2025, from $4456.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $8043.0 in Q3 2021 to a low of -$53805.0 in Q4 2022.
- A 5-year average of -$679.11 and a median of $1436.5 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions plunged 4895.45% — and 2024, when it jumped 485.15%.
- Tracing ICCC's Tax Provisions over 5 years: stood at $1122.0 in 2021, then sank by 4895.45% to -$53805.0 in 2022, then surged by 102.51% to $1348.0 in 2023, then soared by 347.77% to $6036.0 in 2024, then slumped by 45.23% to $3306.0 in 2025.
- The last three Tax Provisions figures came in at $3306.0 (Q4 2025), $4456.0 (Q3 2025), and $1904.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | 45,950.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45,950.00 |
| Dec 31, 2025 | 3,306.00 |
| Sep 30, 2025 | 4,456.00 |
| Jun 30, 2025 | 1,904.00 |
| Mar 31, 2025 | 1,904.00 |
| Dec 31, 2024 | 6,036.00 |
| Sep 30, 2024 | 1,340.00 |
| Jun 30, 2024 | 1,340.00 |
| Mar 31, 2024 | 1,340.00 |
| Dec 31, 2023 | 1,348.00 |
| Sep 30, 2023 | 229.00 |
| Jun 30, 2023 | 1,525.00 |
| Mar 31, 2023 | 1,525.00 |
| Dec 31, 2022 | -53,805.00 |
| Sep 30, 2022 | 3,867.00 |
| Jun 30, 2022 | 1,148.00 |
| Mar 31, 2022 | 1,148.00 |
| Dec 31, 2021 | 1,122.00 |
| Sep 30, 2021 | 8,043.00 |
| Dec 31, 2020 | 19,128.00 |